The effect of micronutrient supplementation on quality-of-life and left ventricular function in elderly patients with chronic heart failure

被引:238
作者
Witte, KKA
Nikitin, NP
Parker, AC
von Haehling, S
Volk, HD
Anker, SD
Clark, AL
Cleland, JGF
机构
[1] Castle Hill Hosp, Dept Acad Cardiol, Kingston Upon Hull HU16 5JQ, N Humberside, England
[2] Imperial Coll Sch Med, Natl Heart & Lung Inst, Dept Clin Cardiol, London, England
[3] Charite Med Sch, Inst Med Immunol, Berlin, Germany
[4] Charite, Dept Cardiol, Div Appl Cachexia Res, Berlin, Germany
关键词
chronic heart failure; micronutrients; quality-of-life; cytokines;
D O I
10.1093/eurheartj/ehi442
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Aims Chronic heart failure (CHF) is a common and leading cause of death in industrialized countries. The potential benefits of micronutrient supplementation in CHF are extensive. Therefore, we examined the influence of long-term multiple micronutrient supplementation on left ventricular (LV) function, levels of pro-inflammatory cytokines, and quality-of-life (QoL) in elderly patients with CHF. Methods and results Thirty CHF patients [age 75.4 (0.7), mean (SEM), LV ejection fraction (LVEF) <= 35%] were randomized to receive capsules containing a combination of high-dose micronutrients (calcium, magnesium, zinc, copper, selenium, vitamin A, thiamine, riboflavin, vitamin B-6, folate, vitamin B-12, vitamin C, vitamin E, vitamin D, and Coenzyme Q10) or placebo for 9 months in a double-blind fashion. All subjects were on stable optimal medical therapy for at least 3 months before enrolment. At randomization and at study end, tumour necrosis factor-alpha and its soluble receptors TNFR-1 and TNFR-2 were measured and six-minute walk test and QoL were assessed. Cardiac magnetic resonance scanning was performed to evaluate cardiac dimensions and LVEF. Two patients died during follow-up. The remaining patients (14 randomized to placebo and 14 to micronutrients) were well matched for LV function, symptoms, and exercise capacity. At the end of the follow-up period, LV volumes were reduced in the intervention group with no change in the placebo group [-13.1 (17.1)% vs. +3.8 (10.0)%; P < 0.05]. LVEF increased by 5.3 +/- 1.4% in the intervention group and was unchanged in the placebo group (P < 0.05). Patients taking micronutrients also had a significant improvement in QoL score between enrolment and study end [+9.5 (1.6)%; P < 0.05], whereas those taking placebo had a slight deterioration [-1.1 (0.8)%; P=0.12]. Six-minute walk test and inflammatory cytokine levels remained unchanged in both groups. Conclusion Long-term multiple micronutrient supplementation can improve LV volumes and LVEF and QoL scores in elderly patients with heart failure due to LV systolic dysfunction.
引用
收藏
页码:2238 / 2244
页数:7
相关论文
共 47 条
[1]  
Altman D., 2000, STAT CONFIDENCE
[2]   Reduction in sample size for studies of remodeling in heart failure by the use of cardiovascular magnetic resonance [J].
Bellenger, NG ;
Davies, LC ;
Francis, JM ;
Coats, AJS ;
Pennell, DJ .
JOURNAL OF CARDIOVASCULAR MAGNETIC RESONANCE, 2000, 2 (04) :271-278
[3]   Shattuck lecture - Cardiovascular medicine at the turn of the millennium: Triumphs, concerns, and opportunities [J].
Braunwald, E .
NEW ENGLAND JOURNAL OF MEDICINE, 1997, 337 (19) :1360-1369
[4]   Influence of concomitant disease on patterns of hospitalization in patients with heart failure discharged from Scottish hospitals in 1995 [J].
Brown, AM ;
Cleland, JGF .
EUROPEAN HEART JOURNAL, 1998, 19 (07) :1063-1069
[5]  
Cleland JGF, 1998, LANCET, V352, P19
[6]   The heart failure revascularisation trial (HEART): rationale, design and methodology [J].
Cleland, JGF ;
Freemantle, N ;
Ball, SG ;
Bonser, RS ;
Camici, P ;
Chattopadhyay, S ;
Dutka, D ;
Eastaugh, J ;
Hampton, J ;
Large, S ;
Norell, MS ;
Pennell, DJ ;
Pepper, J ;
Sanda, S ;
Senior, R ;
Smith, D .
EUROPEAN JOURNAL OF HEART FAILURE, 2003, 5 (03) :295-303
[7]   Cardiovascular critical event pathways for the progression of heart failure -: A report from the ATLAS study [J].
Cleland, JGF ;
Thygesen, K ;
Uretsky, BF ;
Armstrong, P ;
Horowitz, JD ;
Massie, B ;
Packer, M ;
Poole-Wilson, PA ;
Rydén, L .
EUROPEAN HEART JOURNAL, 2001, 22 (17) :1601-1612
[8]   The EuroHeart Failure survey programme - a survey on the quality of care among patients with heart failure in Europe - Part 1: patient characteristics and diagnosis [J].
Cleland, JGF ;
Swedberg, K ;
Follath, F ;
Komajda, M ;
Cohen-Solal, A ;
Aguilar, JC ;
Dietz, R ;
Gavazzi, A ;
Hobbs, R ;
Korewicki, J ;
Madeira, HC ;
Moiseyev, VS ;
Preda, I ;
van Gilst, WH ;
Widimsky, J ;
Freemantle, N ;
Eastaugh, J ;
Mason, J .
EUROPEAN HEART JOURNAL, 2003, 24 (05) :442-463
[9]   A survey on the quality of care among patients with heart failure in Europe [J].
Cleland, JGF ;
Swedberg, K ;
Cohen-Solal, A ;
Cosin-Aguilar, J ;
Dietz, R ;
Follath, F ;
Gavazzi, A ;
Hobbs, R ;
Korewicki, J ;
Madeira, HC ;
Preda, I ;
van Gilst, WH ;
Widimsky, J ;
Mareev, V ;
Mason, J ;
Freemantle, N ;
Eastaugh, J .
EUROPEAN JOURNAL OF HEART FAILURE, 2000, 2 (02) :123-132
[10]  
Collins R, 2002, LANCET, V360, P23, DOI 10.1016/S0140-6736(02)09328-5